tobramycin
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
50 FDA-registered drug labelers
A-S Medication Solutions
Advanced Rx of Tennessee, LLC
Advanced Rx Pharmacy of Tennessee, LLC
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
American Health Packaging
Amneal Pharmaceuticals LLC
Ascend Laboratories, LLC
Asclemed USA, Inc.
Aurobindo Pharma Limited
Bausch & Lomb Americas Inc.
Bausch & Lomb Incorporated
Belcher Pharmaceuticals, LLC
Bryant Ranch Prepack
Chiesi USA, Inc.
Chongqing Daxin Pharmaceutical Co. Ltd.
DirectRX
Dr. Reddy's Laboratories Inc.
Eyevance Pharmaceuticals, LLC
Genericus, Inc.
Gland Pharma Limited
Harrow Eye, LLC
HOVIONE FARMACIENCIA SA
JVET PHARMACEUTICALS LLC
Lifestar Pharma LLC
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
Lupin Pharmaceuticals, Inc.
Micro Labs Limited
NorthStar RxLLC
Novartis Pharmaceuticals Corporation
NuCare Pharmaceuticals,Inc.
Padagis US LLC
Pari Respiratory Equipment, Inc.
Prasco, LLC
Preferred Pharmaceuticals Inc.
Professional Compounding Centers of America
Proficient Rx LP
Redpharm Drug
REMEDYREPACK INC.
Ritedose Pharmaceuticals, LLC
Sandoz Inc
Slate Run Pharmaceuticals, LLC
Somerset Therapeutics, LLC
Sportpharm LLC
St. Mary's Medical Park Pharmacy
Sun Pharmaceutical Industries, Inc.
TAPI Hungary Industries Kft.
Teva Pharmaceutical Works Private Limited Company
Teva Pharmaceuticals USA, Inc.
Viatris Specialty LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 15 drug and cosmetic product listings (FDA).
- •Tobramycin AND Dexamethasone
- •Bethkis
- •Tobramycin
- •Loteprednol etabonate and Tobramycin
- •Tobradex ST
- •Zylet
- •Tobramycin Inhalation
- •Kitabis Pak
Show all 15
- •TOBI
- •TOBI Podhaler
- •Tobramycin Ophthalmic Solution
- •TobraDex
- •Tobramycin Inhalation Solution Pak
- •Tobrex
- •Tobramycin Inhalation Solution
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Tobramycin Solution
06/16/2025Chemical Identity
CAS32986-56-4
PubChem CID36294
DTXSIDDTXSID8023680
FormulaC18H37N5O9
Mol. Weight467.5 g/mol
SMILESC1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N
Data Sources
362942026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tobramycin/cids/JSON
Archive: data/sources/pubchem_name/tobramycin.json
CAS 32986-56-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 32986-56-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json